Literature DB >> 31670748

Moving the Needle Forward With Locoregional Treatment in Unresectable Cholangiocarcinoma-The Jury Is Still Out.

Aaron J Scott1, Rachna T Shroff1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31670748     DOI： 10.1001/jamaoncol.2019.3691

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Advances in stent therapy for malignant biliary obstruction.

Authors:  Xin He; Ying Zhu; Yining Wang; Yuanzhen Hao; Junbo Hong
Journal:  Abdom Radiol (NY)       Date:  2021-01

Review 2.  Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection.

Authors:  Woo Jin Choi; Phil J Williams; Marco P A W Claasen; Tommy Ivanics; Marina Englesakis; Steven Gallinger; Bettina Hansen; Gonzalo Sapisochin
Journal:  Ann Surg Oncol       Date:  2022-02-18       Impact factor: 5.344

Review 3.  Current challenges to underpinning the genetic basis for cholangiocarcinoma.

Authors:  Antonio Cigliano; Xin Chen; Diego F Calvisi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2021-04-23       Impact factor: 3.869

4.  A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.

Authors:  Ayhan Ulusakarya; Abdoulaye Karaboué; Oriana Ciacio; Gabriella Pittau; Mazen Haydar; Pamela Biondani; Yusuf Gumus; Amale Chebib; Wathek Almohamad; Pasquale F Innominato
Journal:  BMC Cancer       Date:  2020-06-03       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.